InsiderClue
Insiders · Profile

Eansor Norman David

President-Protein Sciences at Bio-Techne · Director at Marker Therapeutics. Filing since 4 May 2018. CIK 0001270905

TECH Bio-Techne President-Protein Sciences · 10 trades MRKR Marker Therapeutics, Inc. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
TECH Bio-Techne
12 Nov 2021
President-Protein Sciences
Sold, plan not stated
27,159
$13.69M
95.4%
TECH Bio-Techne
31 Aug 2021
President-Protein Sciences
Sold, plan not stated
1,538
$773.73K
53.9%
MRKR Marker Therapeutics, Inc.
16 Mar 2021
Director
Bought
14,285
$249.99K
588%
TECH Bio-Techne
5 Feb 2021
President-Protein Sciences
Sold, plan not stated
32,933
$12.54M
96.2%
TECH Bio-Techne
29 May 2020
President-Protein Sciences
Sold, plan not stated
7,909
$2.07M
100%
TECH Bio-Techne
28 May 2020
President-Protein Sciences
Sold, plan not stated
3,448
$897.13K
100%
TECH Bio-Techne
22 May 2020
President-Protein Sciences
Sold, plan not stated
12,600
$3.38M
100%
TECH Bio-Techne
21 May 2020
President-Protein Sciences
Sold, plan not stated
11,037
$2.95M
100%
TECH Bio-Techne
4 Mar 2020
President-Protein Sciences
Sold, plan not stated
1,387
$275.57K
100%
TECH Bio-Techne
12 Jun 2019
SVP - Novus Biologicals
Sold, plan not stated
3,117
$670.16K
100%
TECH Bio-Techne
4 May 2018
SVP - Novus Biologicals
Sold, plan not stated
1,136
$164.93K
33.4%
11 decisions on file.